表紙
市場調査レポート

皮膚疾患の治療技術・世界市場

Skin Disease Treatment Technologies and Global Markets

発行 BCC Research 商品コード 271121
出版日 ページ情報 英文 128 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.12円で換算しております。
Back to Top
皮膚疾患の治療技術・世界市場 Skin Disease Treatment Technologies and Global Markets
出版日: 2016年01月01日 ページ情報: 英文 128 Pages
担当者のコメント
BCC Research社のレポートは、Reuter、Wall Street Journal、Fortuneなどで引用されることも多く、それぞれの業界の識者の意見として重きを置かれています。同社レポートを複数冊ご購入の場合年間パッケージのご契約がお得です。詳細は右の担当者のおすすめ商品よりご覧下さい。
概要

当レポートでは、世界の皮膚疾患治療市場について調査分析し、実績・推計データおよびCAGR予測を含めた市場動向の分析、皮膚疾患の4大分類(皮膚炎・癌・免疫疾患・感染症)の分析、皮膚構造・機能、特定の皮膚疾患有病率の上昇と新しい診断・治療オプションに関する議論、製品分類別の市場分析、および主要企業のプロファイルなどをまとめ、概略下記の構成でお届けいたします。

第1章 イントロダクション

第2章 サマリー

第3章 概要

  • 皮膚構造・機能
  • 皮膚の疾患

第4章 主な皮膚疾患

  • 皮膚炎
  • 免疫関連疾患
  • 免疫性水泡性疾患
  • 扁平苔癬
  • 多形性紅斑
  • 乾癬
  • 治療
  • 乾癬治療のメリットとリスク
  • 乾癬パイプライン
  • 乾癬市場
  • 皮膚感染症
  • にきび市場
  • 皮膚がん

第5章 皮膚科学製品:ブランド名別

第6章 現在・将来の市場

  • 先進市場
  • BRIC市場

第7章 皮膚科学産業

  • 業界構造・動向
  • 企業プロファイル

第8章 付録?:用語

第9章 付録?:免疫系

図表リスト

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: PHM127B

REPORT HIGHLIGHTS

The global market for skin disease treatment technologies reached $16.4 billion in 2014 and $17.1 billion in 2015. The market should reach $20.4 billion in 2020, demonstrating a compound annual growth rate (CAGR) of 3.6% from 2015 to 2020.

This report provides:

  • An overview of the global market for treatments of skin diseases, perhaps the most common of human afflications.
  • Analyses of global market trends, with data from 2014, 2015, and projections of compound annual growth rates (CAGRs) through 2020.
  • Focused coverage of four major categories of skin disease of exceptional medical and commercial significance: dermatitis (allergic and contact), cancers (including melanoma), immune disorders (including psoriasis), and infections (bacterial, fungal and viral).
  • Topics such as skin structure and function, diseases of the skin, current treatment options, and unmet clinical needs.
  • Discussion of the evolution of the market, including the rising prevalence of some skin diseases, and new diagnostic and treatment options.
  • Examination of the global market by product categories, such as anti-allergic products, antibacterials, antifungals, antivirals, immunotherapies, and anticancers.
  • Profiles of major players in the industry.

SCOPE OF REPORT

This report discusses the implications of the above-mentioned trends in the context of the current size and growth of the dermatology market, discussed both in global terms and in reference to the most important national markets. Long-standing and emerging companies are discussed, with profiles of their leadership and an update on M&A activity. Five-year global sales forecasts are provided for main drug categories, and breakdowns are provided for several national markets.

ANALYST'S CREDENTIALS

Paul Evers has been involved in analyzing pharmaceutical and medical markets for 20 years. He is the author of several previous BCC Research reports on diseases affecting different organ systems in addition to the skin.

Table of Contents

CHAPTER 1 - INTRODUCTION

  • STUDY GOALS AND OBJECTIVES
  • REASONS FOR DOING THE STUDY
  • SCOPE OF REPORT
  • MARKET ANALYSES AND FORECASTS
  • METHODOLOGY
  • INTENDED AUDIENCE
  • INFORMATION SOURCES
  • ANALYST'S CREDENTIALS
  • RELATED BCC RESEARCH REPORTS
  • BCC RESEARCH WEBSITE
  • DISCLAIMER

CHAPTER 2 - SUMMARY

  • SKIN DISEASE AND ITS TREATMENT
    • DISEASES INCLUDED
    • TREATMENTS
  • ABOUT THE MARKET
    • LEADING COMPANIES
      • SUMMARY TABLE: GLOBAL MARKET FOR SKIN DISEASE TREATMENT TECHNOLOGIES BY REGION, THROUGH 2020 ($ MILLIONS)
      • SUMMARY FIGURE: GLOBAL MARKET FOR SKIN DISEASE TREATMENT TECHNOLOGIES BY REGION, 2013-2020 ($ MILLIONS)

CHAPTER 3 - OVERVIEW

  • SKIN STRUCTURE AND FUNCTIONS
    • STRUCTURE
      • Epidermis
      • Basement Membrane
      • Dermis
      • Hypodermis
    • FUNCTIONS
  • SKIN DISEASES

CHAPTER 4 - MAJOR SKIN DISEASES

  • DERMATITIS
    • SEBORRHEIC DERMATITIS
      • Available Treatments
    • ATOPIC DERMATITIS, ECZEMA
      • Available Treatments
    • CONTACT DERMATITIS
      • Irritant Contact Dermatitis
        • Available Treatments
      • Allergic Contact Dermatitis
        • Available Treatments
    • DERMATITIS PIPELINE
      • TABLE 1: PRODUCTS UNDERGOING RESEARCH AS POTENTIAL TREATMENTS FOR DERMATITIS
      • TABLE 2: GLOBAL MARKET FOR DERMATITIS BY TYPE, THROUGH 2020 ($ MILLIONS)
  • IMMUNE-RELATED CONDITIONS
    • LUPUS ERYTHEMATOSUS
      • Treatments Available
      • Pipeline
        • TABLE 3: COMPOUNDS UNDER DEVELOPMENT FOR CUTANEOUS LUPUS TREATMENT
    • IMMUNOBULLOUS DISEASES
      • Treatments Available
      • Market
        • TABLE 4: GLOBAL MARKET FOR IMMUNE-RELATED SKIN DISEASES BY TYPE, THROUGH 2020 ($ MILLIONS)
    • LICHEN PLANUS
      • Treatments Available
    • ERYTHEMA MULTIFORME
      • Treatments Available
  • PSORIASIS
    • SUBTYPES
      • Plaque Psoriasis
      • Guttate Psoriasis
      • Erythrodermic Psoriasis
      • Pustular Psoriasis
      • Psoriasis of the Nails
    • TREATMENTS AVAILABLE
      • Topical Therapies Available
        • Emollients
        • Keratolytics
        • Topical Corticosteroids
        • Vitamin D3 Products
        • Tazarotene
        • Tar Preparations
        • Anthralin
        • Topical Immunomodulators
        • Intralesional Therapy
        • Phototherapy with UVB
        • Photochemotherapy (PUVA)
      • Systemic Therapy
        • Methotrexate
        • Acitretin
        • Cyclosporine
        • Hydroxyurea
        • Cytokine Antagonists and Other Immunomodulators
    • PSORIASIS TREATMENT BENEFITS AND RISKS
    • MAJOR ENGINEERED PROTEIN TREATMENTS IN USE
      • Etanercept (Enbrel)
      • Adalimumab (Humira)
      • Infliximab (REMICADE)
      • Ustekinumab (STELARA)
      • Alefacept (Amevive)
      • Cost of Treatment
        • TABLE 5: COST OF PSORIASIS THERAPIES IN A TYPICAL WESTERN EUROPEAN COUNTRY ($)
    • PSORIASIS TREATMENT PIPELINE
    • PSORIASIS TREATMENT MARKET
      • TABLE 6: GLOBAL MARKET FOR PSORIASIS BY REGION, THROUGH 2020 ($ MILLIONS)
  • SKIN INFECTIONS
    • BACTERIAL INFECTIONS
      • Impetigo/Ecthyma
      • Cellulitis
        • Treatments Available
      • Necrotizing Subcutaneous Infection
        • Treatments Available
    • FUNGAL INFECTIONS
      • Candidiasis
        • Treatments Available
          • TABLE 7: ANTIFUNGALS FOR SUPERFICIAL FUNGAL INFECTIONS
      • Tinea Versicolor
        • Treatments Available
    • VIRAL INFECTIONS
      • Herpes Simplex
        • Treatments Available
      • Herpes Zoster
        • Treatments Available
      • Warts
        • Treatments Available
          • TABLE 8: ANTIVIRAL DRUGS AVAILABLE
    • SKIN INFECTION TREATMENT PIPELINE
      • TABLE 9: POTENTIAL DRUG CANDIDATES FOR SKIN INFECTION TREATMENTS
    • ANTI-INFECTIVE MARKET
      • TABLE 10: GLOBAL MARKET FOR SKIN INFECTIONS BY TYPE, THROUGH 2020 ($ MILLIONS)
    • ACNE
      • Comedonal
      • Papulopustular
      • Nodulocystic
      • Treatments Available
        • Retinoids
        • Antibiotics
        • Anti-inflammatory Drugs
        • Hormonal Therapy
      • Treatment Failure
    • ACNE TREATMENT PIPELINE
      • TABLE 11: POTENTIAL PRODUCTS FOR ACNE TREATMENT
    • ACNE TREATMENT MARKET
      • TABLE 12: GLOBAL MARKET FOR ACNE MEDICATIONS BY TYPE, THROUGH 2020 ($ MILLIONS)
  • SKIN CANCERS
    • MELANOMA
      • Treatments Available
    • NONMELANOMA SKIN CANCERS
      • Basal Cell Carcinoma
      • Squamous Cell Carcinoma
    • SKIN CANCER TREATMENT PIPELINE
      • TABLE 13: PRODUCTS IN PIPELINE FOR SKIN CANCER THERAPEUTICS
    • SKIN CANCER TREATMENT MARKET
      • TABLE 14: GLOBAL MARKET FOR SKIN CANCER THERAPEUTICS, THROUGH 2020 ($ MILLIONS)

CHAPTER 5 - DERMATOLOGY PRODUCTS

  • DESCRIPTIONS

CHAPTER 6 - CURRENT AND FORECAST MARKETS

  • DEVELOPED MARKETS
    • U.S.
      • TABLE 15: U.S. ANNUAL DIRECT COST OF PRESCRIPTION DRUGS, 2004 ($ MILLIONS)
      • TABLE 16: U.S. MARKET FOR PRESCRIPTION DERMATOLOGY DRUGS, THROUGH 2020 ($ MILLIONS/%)
    • JAPAN
      • TABLE 17: JAPANESE MARKET FOR PRESCRIPTION DERMATOLOGY DRUGS, THROUGH 2020 ($ MILLIONS/%)
    • GERMANY
      • TABLE 18: GERMAN MARKET FOR PRESCRIPTION DERMATOLOGY DRUGS, THROUGH 2020 ($ MILLIONS/%)
    • FRANCE
      • TABLE 19: FRENCH MARKET FOR PRESCRIPTION DERMATOLOGY DRUGS, THROUGH 2020 ($ MILLIONS/%)
    • ITALY
      • TABLE 20: ITALIAN MARKET FOR PRESCRIPTION DERMATOLOGY DRUGS, THROUGH 2020 ($ MILLIONS/%)
    • SPAIN
      • TABLE 21: SPAIN'S MARKET FOR PRESCRIPTION DERMATOLOGY DRUGS, THROUGH 2020 ($ MILLIONS/%)
    • UNITED KINGDOM
      • TABLE 22: U.K. MARKET FOR PRESCRIPTION DERMATOLOGY DRUGS, THROUGH 2020 ($ MILLIONS/%)
  • BRIC MARKETS
    • BRAZIL
      • TABLE 23: BRAZILIAN MARKET FOR PRESCRIPTION DERMATOLOGY DRUGS, THROUGH 2020 ($ MILLIONS/%)
    • RUSSIA
      • TABLE 24: RUSSIAN MARKET FOR PRESCRIPTION DERMATOLOGY DRUGS, THROUGH 2020 ($ MILLIONS/%)
    • INDIA
      • TABLE 25: INDIA'S MARKET FOR PRESCRIPTION DERMATOLOGY DRUGS, THROUGH 2020 ($ MILLIONS/%)
    • CHINA
      • TABLE 26: HEALTHCARE STATISTICS IN CHINA, 2006 VERSUS 2011 ($ BILLIONS/%)
      • TABLE 27: CHINESE MARKET FOR PRESCRIPTION DERMATOLOGY DRUGS, THROUGH 2020 ($ MILLIONS/%)

CHAPTER 7 - THE DERMATOLOGY INDUSTRY

  • INDUSTRY STRUCTURE AND TRENDS
  • COMPANY PROFILES
    • ABBVIE
    • AGENUS
    • AICURIS GMBH & CO. KG
    • ALLERGAN
    • ALMIRALL
    • AMGEN
    • ANACOR PHARMACEUTICALS INC.
    • ANGES MG
    • APEIRON BIOLOGICS AG
    • ASTELLAS PHARMA INC.
    • ASTION PHARMA A/S
    • ASTRAZENECA
    • BARRIER THERAPEUTICS
    • BASILEA PHARMACEUTICA LTD.
    • BRISTOL-MYERS SQUIBB
    • CELGENE
    • CIPHER PHARMACEUTICALS
    • DUSA PHARMACEUTICALS INC.
    • ELI LILLY
    • GALDERMA PHARMA SA/GALDERMA SA
    • GENENTECH
    • GLAXOSMITHKLINE
    • HANALL BIOPHARMA
    • IMMUNE TECHNOLOGIES & MEDICINE
    • INCYTE
    • JANSSEN BIOTECH
    • KAKEN PHARMACEUTICALS
    • LEO PHARMA A/S
    • MEDA AB
    • NANOBIO
    • NAVIDEA BIOPHARMACEUTICALS
    • NITRIC BIOTHERAPEUTICS
    • NOVARTIS INTERNATIONAL
    • PFIZER
    • PHOTOCURE
    • REGENERON PHARMACEUTICALS INC.
    • STIEFEL, A GSK COMPANY
    • SWITCH BIOTECH
    • VALEANT PHARMACEUTICALS INTERNATIONAL INC.

CHAPTER 8 - APPENDIX I: GLOSSARY

CHAPTER 9 - APPENDIX II: THE IMMUNE SYSTEM

  • TWO DEFENSE STRATEGIES
    • HUMORAL IMMUNITY
    • CELLULAR IMMUNITY
  • MARKERS OF SELF
  • HUMORAL IMMUNITY: B LYMPHOCYTES
  • CELLULAR IMMUNITY: T LYMPHOCYTES
    • REGULATORY T CELLS
    • CYTOTOXIC T CELLS
  • NATURAL IMMUNITY
    • TABLE 28: IMMUNOTHERAPEUTICS IN SKIN DISEASES

LIST OF TABLES

  • SUMMARY TABLE: GLOBAL MARKET FOR SKIN DISEASE TREATMENT TECHNOLOGIES BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 1: PRODUCTS UNDERGOING RESEARCH AS POTENTIAL TREATMENTS FOR DERMATITIS
    • TABLE 2: GLOBAL MARKET FOR DERMATITIS BY TYPE, THROUGH 2020 ($ MILLIONS)
    • TABLE 3: COMPOUNDS UNDER DEVELOPMENT FOR CUTANEOUS LUPUS TREATMENT
    • TABLE 4: GLOBAL MARKET FOR IMMUNE-RELATED SKIN DISEASES BY TYPE, THROUGH 2020 ($ MILLIONS)
    • TABLE 5: COST OF PSORIASIS THERAPIES IN A TYPICAL WESTERN EUROPEAN COUNTRY ($)
    • TABLE 6: GLOBAL MARKET FOR PSORIASIS BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 7: ANTIFUNGALS FOR SUPERFICIAL FUNGAL INFECTIONS
    • TABLE 8: ANTIVIRAL DRUGS AVAILABLE
    • TABLE 9: POTENTIAL DRUG CANDIDATES FOR SKIN INFECTION TREATMENTS
    • TABLE 10: GLOBAL MARKET FOR SKIN INFECTIONS BY TYPE, THROUGH 2020 ($ MILLIONS)
    • TABLE 11: POTENTIAL PRODUCTS FOR ACNE TREATMENT
    • TABLE 12: GLOBAL MARKET FOR ACNE MEDICATIONS BY TYPE, THROUGH 2020 ($ MILLIONS)
    • TABLE 13: PRODUCTS IN PIPELINE FOR SKIN CANCER THERAPEUTICS
    • TABLE 14: GLOBAL MARKET FOR SKIN CANCER THERAPEUTICS, THROUGH 2020 ($ MILLIONS)
    • TABLE 15: U.S. ANNUAL DIRECT COST OF PRESCRIPTION DRUGS, 2004 ($ MILLIONS)
    • TABLE 16: U.S. MARKET FOR PRESCRIPTION DERMATOLOGY DRUGS, THROUGH 2020 ($ MILLIONS/%)
    • TABLE 17: JAPANESE MARKET FOR PRESCRIPTION DERMATOLOGY DRUGS, THROUGH 2020 ($ MILLIONS/%)
    • TABLE 18: GERMAN MARKET FOR PRESCRIPTION DERMATOLOGY DRUGS, THROUGH 2020 ($ MILLIONS/%)
    • TABLE 19: FRENCH MARKET FOR PRESCRIPTION DERMATOLOGY DRUGS, THROUGH 2020 ($ MILLIONS/%)
    • TABLE 20: ITALIAN MARKET FOR PRESCRIPTION DERMATOLOGY DRUGS, THROUGH 2020 ($ MILLIONS/%)
    • TABLE 21: SPAIN'S MARKET FOR PRESCRIPTION DERMATOLOGY DRUGS, THROUGH 2020 ($ MILLIONS/%)
    • TABLE 22: U.K. MARKET FOR PRESCRIPTION DERMATOLOGY DRUGS, THROUGH 2020 ($ MILLIONS/%)
    • TABLE 23: BRAZILIAN MARKET FOR PRESCRIPTION DERMATOLOGY DRUGS, THROUGH 2020 ($ MILLIONS/%)
    • TABLE 24: RUSSIAN MARKET FOR PRESCRIPTION DERMATOLOGY DRUGS, THROUGH 2020 ($ MILLIONS/%)
    • TABLE 25: INDIA'S MARKET FOR PRESCRIPTION DERMATOLOGY DRUGS, THROUGH 2020 ($ MILLIONS/%)
    • TABLE 26: HEALTHCARE STATISTICS IN CHINA, 2006 VERSUS 2011 ($ BILLIONS/%)
    • TABLE 27: CHINESE MARKET FOR PRESCRIPTION DERMATOLOGY DRUGS, THROUGH 2020 ($ MILLIONS/%)
    • TABLE 28: IMMUNOTHERAPEUTICS IN SKIN DISEASES

LIST OF FIGURES

  • SUMMARY FIGURE: GLOBAL MARKET FOR SKIN DISEASE TREATMENT TECHNOLOGIES BY REGION, 2013-2020 ($ MILLIONS)
Back to Top